Patients post out-of-hospital cardiac arrest (OHCA) are common admissions to the ICU. Th erapeutic hypothermia has been shown to improve both survival and neurological outcome for OHCA patients surviving to reach the ICU and now forms part of routine postresuscitation care. Th e Time to Target Temperature (TTTT) study group presents key observations on the relation ship between body temperature and outcome following OHCA [1] , yet ultimately are we left with more questions than answers on therapeutic hypothermia?
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Nearly a decade ago two landmark papers fundamentally changed the practice of post-resuscitation care. Th e Hypothermia after Cardiac Arrest study group [2] and Bernard and colleagues [3] not only demonstrated the benefi t of cooling OHCA patients but also highlighted how hugely eff ective the therapy was, with a number needed to treat of seven patients and six patients, respectively, for survival. Such impressive therapeutic benefi t is rarely seen in medical practice, let alone in critical care medicine. A key diff er ence between these two studies was the time from return of spontaneous circulation (ROSC) to the onset of cooling. Th e time to reach the target temperature (<34°C) varied greatly from immediately post ROSC to over 16 hours post ROSC and yet the therapeutic benefi t of cooling was still evident. Th e TTTT group demonstrated that the change in body temperature during the period from ROSC to cooling initiation has a direct relationship on survival [1] .
Since 2002 few studies have examined the optimum method, rate of cooling and timing of initiation. Little is known about the mechanism of action of therapeutic hypothermia. Whilst animal evidence strongly suggests that early cooling, especially intra-arrest, is benefi cial, few human studies have demonstrated a benefi t from early cooling. Early cooling, in the prehospital or emer gency department setting, has signifi cant technical challenges and may distract from the basic principles of resuscitation. Yet emerging evidence suggests that cold reperfusion at the time of ROSC may confer greater benefi t in limiting ischaemic-reperfusion injury. For cold reperfusion to occur, very rapid intra-arrest cooling would be required and some novel intranasal cooling devices have shown promising initial results [4] . Previous studies have demonstrated that most OHCA patients are relatively hypothermic in the prehospital phase, and whether initiating cooling, maintaining hypothermia or even normothermia would confer survival benefi t remains unknown [5] . Although OHCA patients are naturally hypothermic in the immediate phase following collapse, they may still benefi t from early therapeutic cooling.
Th e TTTT group elegantly demonstrate that OHCA patients destined for a favourable outcome re-warm rapidly post OHCA, are warmer at cooling initiation and take longer to reach the target therapeutic temperature than OHCA patients destined for an unfavourable outcome. Th is observation appears contradictory to the notion that earlier, faster cooling favours a positive outcome post OHCA. No defi nitive explanation can yet be off ered for the TTTT group fi nding. Unfavourable OHCA patients would appear to lack the homeostatic mechanism to regulate body temperature and appear to cool faster than favourable patients. Underlying mechanisms are postulated to include ischaemic hypothalamic damage and the inability of hypoxic mitochondria to generate heat.
